Biological agents cost effective in the treatment of RA

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1402, 2003-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biological agents cost effective in the treatment of RA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 426, 2003-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Infliximab may be cost effective in severe, treatment-resistant RA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Infliximab may be cost effective in severe, treatment-resistant RA

By  

Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Etanercept considered cost effective vs DMARDs in RA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 446, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Economics of biological agents for RA weighed up

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite